4-(4-bromobutyl)-2,3,4,5-tetrahydro-1,4-benzoxazepin-3-one | 140691-19-6

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 苯并恶嗪类
• 英文名称: 4-(4-bromobutyl)-2,3,4,5-tetrahydro-1,4-benzoxazepin-3-one
• 英文别名: 4-(4-bromobutyl)-5H-1,4-benzoxazepin-3-one
• CAS: 140691-19-6
• 化学式: C₁₃H₁₆BrNO₂
• 分子量: 298.18
• InChiKey: MOYGIJBNYBUMFP-UHFFFAOYSA-N

物化性质

• 沸点：
  450.4±45.0 °C(Predicted)
• 密度：
  1.378±0.06 g/cm3(Predicted)

计算性质

• 辛醇/水分配系数(LogP)：
  2.5
• 重原子数：
  17
• 可旋转键数：
  4
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.46
• 拓扑面积：
  29.5
• 氢给体数：
  0
• 氢受体数：
  2

反应信息

• 作为反应物：
  描述：

  4-(4-bromobutyl)-2,3,4,5-tetrahydro-1,4-benzoxazepin-3-one 、 1-(3-氯苯基)哌嗪 以 1,4-二氧六环 为溶剂， 生成 4-(4-(4-(3-chlorophenyl)piperazinyl)butyl)-2,3,4,5-tetrahydro-1,4-benzoxazepine-3,5-dione
  参考文献：
  名称：

  Benzoxazepine derivative

  摘要：

  一种适用于用作精神药物组合物的苯并噁唑啶衍生物，其化学式为：##STR1## 其中A和B均为羰基，或其中一个代表亚甲基，另一个代表羰基，R代表芳香基或杂环基，可以被取代，X代表氢原子、卤原子、C.sub.1-C.sub.5低烷基、C.sub.1-C.sub.5低烷氧基、C.sub.7-C.sub.9芳基烷氧基、羟基、硝基或酯基，n为2至10的整数及其盐。

  公开号：

  US05071845A1
• 作为产物：
  描述：

  benzo[f][1,4]thiazepine-3,5-dione 在 sodium hydride 、 potassium carbonate 作用下， 以 二氯甲烷 、 N,N-二甲基甲酰胺 、 丙酮 为溶剂， 反应 6.5h， 生成 4-(4-bromobutyl)-2,3,4,5-tetrahydro-1,4-benzoxazepin-3-one
  参考文献：
  名称：

  Synthesis, SAR studies, and evaluation of 1,4-benzoxazepine derivatives as selective 5-HT1A receptor agonists with neuroprotective effect: Discovery of Piclozotan

  摘要：

  A new series of 1,4-benzoxazepine derivatives was designed, synthesized, and evaluated for binding to 5-HT1A receptor and cerebral anti-ischemic effect. A lot of compounds exhibited nanomolar affinity for 5-HT1A receptor with good selectivity over both dopamine D, and alpha(1)-adrenergic receptors. Among these compounds, 3-chloro-4-[4-[4-(2-pyridinyl)-1,2,3,6-tetrahydropyridin-1-y]butyl]-1, 4-benzoxazepin-5(4H)-one (50: SUN N4057 (Piclozotan) as 2HCl salt) showed remarkable neuroprotective activity in a transient middle cerebral artery occlusion (t-MCAO) model. (c) 2005 Elsevier Ltd. All rights reserved.

  DOI：

  10.1016/j.bmc.2005.10.046

文献信息

• Benzoxazepine derivatives
  申请人：SUNTORY LIMITED

  公开号：EP0376633A2

  公开（公告）日：1990-07-04

  A benzoxazepine derivative suitable for use as a psychotropic composition having the formula: wherein A and B are both carbonyl groups, or one thereof represents a methylene group and the other a carbonyl group, R represents an aromatic group or a heterocyclic group, which may be substituted, X represents a hydrogen atom, a halogen atom, a Ci - C5 lower alkyl group, a C1- Cs lower alkoxy group, a C7 - C9 arylalkoxy group, a hydroxyl group, a nitro group, or an ester group, and n is an integer of 2 to 10, or a salt thereof.

  一种适合用作精神药物的苯并氧氮杂卓衍生物，其式如下 其中 A 和 B 均为羰基，或其中一个代表亚甲基，另一个代表羰基，R 代表芳香基团或杂环基团，可被取代，X 代表氢原子、卤素原子、Ci-C5 低级烷基、C1-Cs 低级烷氧基、C7-C9 芳基烷氧基、羟基、硝基或酯基，n 为 2-10 的整数，或其盐。
• Heterocyclic compound and psychopharmaceutical composition containing same
  申请人：SUNTORY LIMITED

  公开号：EP0463810A1

  公开（公告）日：1992-01-02

  A condensed heterocyclic compound having the formula (I): wherein A and B are both carbonyl groups or one thereof represents a methylene group and the other represents a carbonyl group; Z represents an oxygen atom, a sulfur atom, a substituted or unsubstituted nitrogen atom, or a methylene group; n is an integer of 2 to 6; and R represents a group having the following formula: wherein R¹ represents a hydrogen atom or a hydroxyl group; R² represents a substituted or unsubstituted phenyl or 2-pyridyl group or salts thereof. The compounds exhibit a strong affinity to the σ-receptor and are useful as psychopharmaceuticals.

  具有式 (I) 的缩合杂环化合物： 其中 A 和 B 都是羰基，或其中一个代表亚甲基，另一个代表羰基；Z 代表氧原子、硫原子、取代或未取代的氮原子或亚甲基；n 是 2 到 6 的整数；R 代表具有下式的基团： 其中 R¹ 代表氢原子或羟基；R² 代表取代或未取代的苯基或 2-吡啶基或其盐类。 这些化合物对 σ 受体有很强的亲和力，可用作精神药物。
• US5071845A
  申请人：——

  公开号：US5071845A

  公开（公告）日：1991-12-10
• US5158947A
  申请人：——

  公开号：US5158947A

  公开（公告）日：1992-10-27
• Synthesis, SAR studies, and evaluation of 1,4-benzoxazepine derivatives as selective 5-HT1A receptor agonists with neuroprotective effect: Discovery of Piclozotan
  作者：Katsuhide Kamei、Noriko Maeda、Kayoko Nomura、Makoto Shibata、Ryoko Katsuragi-Ogino、Makoto Koyama、Mika Nakajima、Teruyoshi Inoue、Tomochika Ohno、Toshio Tatsuoka

  DOI：10.1016/j.bmc.2005.10.046

  日期：2006.3

  A new series of 1,4-benzoxazepine derivatives was designed, synthesized, and evaluated for binding to 5-HT1A receptor and cerebral anti-ischemic effect. A lot of compounds exhibited nanomolar affinity for 5-HT1A receptor with good selectivity over both dopamine D, and alpha(1)-adrenergic receptors. Among these compounds, 3-chloro-4-[4-[4-(2-pyridinyl)-1,2,3,6-tetrahydropyridin-1-y]butyl]-1, 4-benzoxazepin-5(4H)-one (50: SUN N4057 (Piclozotan) as 2HCl salt) showed remarkable neuroprotective activity in a transient middle cerebral artery occlusion (t-MCAO) model. (c) 2005 Elsevier Ltd. All rights reserved.